𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetic-pharmacodynamic modeling and simulation

✍ Scribed by Peter L Bonate,SpringerLink (Online service)

Book ID
127461000
Publisher
Springer
Year
2005
Tongue
English
Weight
8 MB
Category
Library
City
New York, NY
ISBN
0387271996

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetic/pharmacodynamic modeling
Pharmacokinetic/pharmacodynamic modeling and simulation to determine effective dosage regimens for doripenem
✍ Katsube, Takayuki (author);Yano, Yoshitaka (author);Wajima, Toshihiro (author);Y 📂 Article 📅 2010 🏛 John Wiley and Sons Inc. 🌐 English ⚖ 170 KB

The aim of this study was to obtain information on effective dosage regimens of doripenem by a modeling and simulation approach based on pharmacokinetic (PK)/pharmacodynamic (PD) theory. The PK/PD model we have already developed was modified to explain in vitro bactericidal kinetics of doripenem for

Pharmacokinetic–pharmacodynamic modeling
Pharmacokinetic–pharmacodynamic modeling and simulation for in vivo bactericidal effect in murine infection model
✍ Takayuki Katsube; Yoshinori Yamano; Yoshitaka Yano 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB

A pharmacokinetic (PK)/pharmacodynamic (PD) modeling strategy to simulate in vivo bactericidal effects for three carbapenem antibiotics, doripenem (DRPM), meropenem (MEPM)/cilastatin (CS), and imipenem (IPM)/CS, against a Pseudomonas aeruginosa (P. aeruginosa) strain is proposed. The PD model we hav

Pharmacokinetic–pharmacodynamic modeling
Pharmacokinetic–pharmacodynamic modeling and simulation for bactericidal effect in an in vitro dynamic model
✍ Takayuki Katsube; Yoshitaka Yano; Yoshinori Yamano; Tadashi Munekage; Naomi Kuro 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

A pharmacokinetic (PK)/pharmacodynamic (PD) modeling strategy to explain the data from an in vitro dynamic model is proposed. Two carbapenem antibiotics, doripenem and meropenem, and three Pseudomonas aeruginosa strains were used as example drugs and strains. The PD model we originally developed to

[AAPS Advances in the Pharmaceutical Sci
[AAPS Advances in the Pharmaceutical Sciences Series] Clinical Trial Simulations Volume 1 || Application of Pharmacokinetic–Pharmacodynamic Modeling and Simulation for Erythropoietic Stimulating Agents
✍ Kimko, Holly H. C.; Peck, Carl C. 📂 Article 📅 2010 🏛 Springer New York 🌐 English ⚖ 282 KB

There have been tremendous advancements in application of modeling and simulation (M&S) in drug development during the last decade. The pharmaceutical companies started to pay more attention to implement simulation exercises in drug development in order to achieve cost effectiveness. The Food and Dr